Form 4 for FTH Faeth Therapeutics, Inc.

Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-10 · accession 0001209191-22-036668 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-14	2022-06-10	FTH	RICKS THOMAS G	Dir	A - Grant	$0.00	+4,466	4,466	New	$0
D	2022-06-14	2022-06-10	FTH	RICKS THOMAS G	Dir	A - Grant	$0.00	+14.6K	14.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-10	A	A	4,466	$0.00	4,466	D	—	—	(F1) These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
2	Derivative	Stock Option (Right to Buy)	2022-06-10	A	A	14,550	$0.00	14,550	D	$2.05 · — to 2032-06-09	14,550 Common Stock	(F3) The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.